Welcome to LookChem.com Sign In|Join Free

CAS

  • or

653604-33-2

Post Buying Request

653604-33-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

653604-33-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 653604-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,3,6,0 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 653604-33:
(8*6)+(7*5)+(6*3)+(5*6)+(4*0)+(3*4)+(2*3)+(1*3)=152
152 % 10 = 2
So 653604-33-2 is a valid CAS Registry Number.

653604-33-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-[N-(4-(tert-butoxycarbonylaminomethyl)phenyl)carbamyl]-2-naphthalenecarbonitrile

1.2 Other means of identification

Product number -
Other names {4-[(6-Cyano-naphthalene-2-carbonyl)-amino]-benzyl}-carbamic acid tert-butyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:653604-33-2 SDS

653604-33-2Downstream Products

653604-33-2Relevant articles and documents

Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)

Venkatraj, Muthusamy,Messagie, Jonas,Joossens, Jurgen,Lambeir, Anne-Marie,Haemers, Achiel,Van Der Veken, Pieter,Augustyns, Koen

, p. 1557 - 1568 (2012/04/17)

Recent drug discovery programs targeting urokinase plasminogen activator (uPA) have resulted in nonpeptidic inhibitors consisting of amidine or guanidine functional groups attached to aromatic or heteroaromatic scaffolds. There is a general problem of poor oral bioavailability of these charged inhibitors. In this paper, we report the synthesis and evaluation of a series of naphthamide and naphthalene sulfonamides as uPA inhibitors containing non-basic groups as substitute for amidine or guanidine groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 653604-33-2